Clinical and Lab Diagnostics - Using synthetic peptides for inflammatory disease diagnosis
Can't see this email? View it online
   
  Clinical and Lab Diagnostics  
  The latest clinical and lab diagnostics news from News Medical  
 

Big Look at Microscale InnovationBig Look at Microscale Innovation

Join researchers and technology providers at SLAS’s new Microscale Innovation in Life Sciences Symposia, a two-day intensive look at the cutting-edge applications of these small methods that bring huge potential for scientific breakthroughs.

Tracks include Microscale Innovation for Translational Applications; Microfluidics; Advances in Organ-on-Chip Platforms; and Next Generation Miniaturization Technologies. Abstract submission for podium and poster talks and registration are open now. Exhibit and sponsorship opportunities are available.

Register Now
 
   Using synthetic peptides for inflammatory disease diagnosisUsing synthetic peptides for inflammatory disease diagnosis
 
Scientists have developed a peptide that binds to the protein calprotectin, a marker of major inflammatory disorders, and shown that it is suitable for diagnostic tests.
 
   Is COVID-19 diagnosis associated with the risk and incidence of type 1 diabetes?Is COVID-19 diagnosis associated with the risk and incidence of type 1 diabetes?
 
Researchers assessed the incidence and risk of type 1 diabetes in children with coronavirus disease 2019.
 
 Study reveals type 2 diabetes diagnosis spurs cholesterol shifts, alters cardiovascular risk
 
Study reveals type 2 diabetes diagnosis spurs cholesterol shifts, alters cardiovascular riskA recent study published in the journal Scientific Reports assessed the associations between the change in total cholesterol (TC) levels after type 2 diabetes (T2D) diagnosis (relative to pre-diagnosis levels) and the risk of cardiovascular disease (CVD).
 
 
 Gout unveiled as surprising culprit in neurodegenerative diseases
 
Gout unveiled as surprising culprit in neurodegenerative diseasesResearch highlights the association between gout and neurodegenerative diseases, revealing that gout patients exhibit smaller brain volumes, increased brain iron markers, and a higher incidence of conditions such as dementia, Parkinson's disease, and essential tremor, particularly within the first three years after diagnosis.
 
 
 New tests based on biomarkers may improve diagnosis and treatment of acute kidney injury
 
New tests based on biomarkers may improve diagnosis and treatment of acute kidney injuryHospital inpatients who develop an acute kidney injury (AKI) generally fare poorly after being discharged, and have few options for effective treatment.
 
 
 New liquid biopsy tool shows 30% increased sensitivity in detecting ctDNA
 
New liquid biopsy tool shows 30% increased sensitivity in detecting ctDNAPancreatic cancer is the seventh leading cause of cancer death worldwide and despite the increasing incidence of this disease, effective treatments are lacking and prognosis for patients with this tumor type remains poor, with approximately 70% of patients dying within one year of diagnosis.
 
 
 Redefining menstrual migraines: New criteria for accurate diagnosis and improved treatment response
 
Redefining menstrual migraines: New criteria for accurate diagnosis and improved treatment responseMenstrual migraine, a specific type of migraine affecting women, leads to significant disability and impacts the quality of life during reproductive stages. Understanding its prevalence and impact is crucial for effective management.
 
 
 Efficient assay system aids rapid genetic diagnosis of mitochondrial diseases
 
Efficient assay system aids rapid genetic diagnosis of mitochondrial diseasesThe gene ECHS1 encodes for enoyl-CoA hydratase short-chain 1, a mitochondrial enzyme involved in branched-chain amino acid and fatty acid metabolism.
 
 
 Deep learning–based computer-aided diagnosis for breast lesion classification
 
Deep learning–based computer-aided diagnosis for breast lesion classificationAccording to an accepted manuscript published in ARRS' own American Journal of Roentgenology (AJR), deep learning–based computer-aided diagnosis (CAD) for breast lesion classification on ultrasound significantly improved radiologists' diagnostic performance-;particularly for reducing the frequency of benign breast biopsies.
 
 

Your feedback matters!
Tell us what you think

Click the button below to complete a quick survey on your newsletter experience, or send us your feedback by replying to this email.

Submit feedback